查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
抗瘧疾藥的全球市場 - 產業規模，佔有率，趨勢，機會，預測(2018年～2028年):各藥品類型，各級藥品，各給藥途徑，各瘧疾類型，各用途，各地區，預測，機會(2028年)
市場調查報告書
商品編碼
1174490

抗瘧疾藥的全球市場 - 產業規模，佔有率，趨勢，機會，預測(2018年～2028年):各藥品類型，各級藥品，各給藥途徑，各瘧疾類型，各用途，各地區，預測，機會(2028年)

Global Antimalarial Drugs Market-Global Industry Size, Share, Trends, Opportunity, & Forecast, 2018-2028 Segmented By Drug Type, Drug Class, Route of Administration, Malaria Type, Application, Region, Forecast & Opportunities, 2028
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球抗瘧疾藥市場在2024年～2028年的預測期間內將展現驚人成長。

瘧疾的流行，新抗瘧疾藥的研究劇增，促進了市場成長。

本報告提供全球抗瘧疾藥市場相關調查分析，提供市場規模與預測，各地區預測，競爭情形等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 VOC (客戶的迴響)

第5章 臨床試驗分析

  • 進行中的臨床試驗
  • 達成的臨床試驗
  • 結束的臨床試驗
  • 開發平台(管線)的明細:各開發階段
  • 開發平台(管線)的明細:各狀態
  • 開發平台(管線)的明細:各研究類型
  • 開發平台(管線)的明細:各國
  • 臨床試驗熱圖

第6章 全球抗瘧疾藥市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
    • 各藥品類型(奎寧，Chloroquine，氯胍，阿莫地奎，甲氟奎，羥氯奎，乙胺嘧啶，其他)
    • 各級藥品(丙烯基胺基酒精化合物，抗葉酸化合物，青蒿素化合物，抗菌藥)
    • 各給藥途徑(口服，粉末吸入，靜脈注射)
    • 各瘧疾類型(熱帶熱瘧疾原蟲，間日熱瘧疾原蟲，三日熱瘧疾原蟲，卵形瘧疾原蟲，諾氏瘧原蟲)
    • 各用途(預防，瘧疾的治療)
    • 各流通管道(醫院藥局，零售藥局，電子商務，其他)
    • 各企業(2022年)
    • 各地區
  • 產品市場地圖

第7章 亞太地區的抗瘧疾藥市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
  • 亞太地區:各國分析
    • 中國的抗瘧疾藥市場預測
    • 印度的抗瘧疾藥市場預測
    • 日本的抗瘧疾藥市場預測
    • 韓國的抗瘧疾藥市場預測
    • 新加坡的抗瘧疾藥市場預測
    • 澳洲的抗瘧疾藥市場預測

第8章 歐洲的抗瘧疾藥市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
  • 歐洲:各國分析
    • 法國的抗瘧疾藥市場預測
    • 德國的抗瘧疾藥市場預測
    • 英國的抗瘧疾藥市場預測
    • 義大利的抗瘧疾藥市場預測
    • 西班牙的抗瘧疾藥市場預測

第9章 北美的抗瘧疾藥市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
  • 北美:各國分析
    • 美國的抗瘧疾藥市場預測
    • 墨西哥的抗瘧疾藥市場預測
    • 加拿大幅抗瘧疾藥市場預測

第10章 南美的抗瘧疾藥市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
  • 南美:各國分析
    • 巴西的抗瘧疾藥市場預測
    • 阿根廷的抗瘧疾藥市場預測
    • 哥倫比亞的抗瘧疾藥市場預測

第11章 中東·非洲的抗瘧疾藥市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
  • 中東·非洲:各國分析
    • 南非的抗瘧疾藥市場預測
    • 沙烏地阿拉伯的抗瘧疾藥市場預測
    • 阿拉伯聯合大公國的抗瘧疾藥市場預測

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • 競爭預測
  • 被側寫的企業(主要企業)
    • Cipla Ltd
    • GlaxoSmithKline Plc
    • Ipca Laboratories Ltd.
    • Merck & Co., Inc
    • Novartis AG
    • Zydus Cadila
    • Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)
    • Strides Pharma Science Limited
    • Glenmark Pharmaceuticals Ltd.
    • Lincoln Pharmaceuticals Ltd.

第15章 策略性建議

簡介目錄
Product Code: 5012

Global antimalarial drugs market is expected to register impressive growth during the forecast period, 2024-2028. Increasing prevalence of malaria coupled with surge in research for new antimalarial drugs is anticipated to propel the growth of the market. According to the "World Malaria Report 2021" by World Health Organization (WHO), in 2020, there were approximately 228 million cases and about 6,02,000 malaria-related deaths. Moreover, the increase in awareness initiatives by governments is also a key factor for growth of antimalarial drugs market. In 2021, the government of Malawi launched a 'Zero Malaria Starts with Me' campaign to stop malaria by the year 2030, which is the leading cause of death in Malawi.

Additionally, rise in malaria death cases, especially in developing nations are also fueling the growth of antimalarial drugs market. According to World Health Organization (WHO), about half of the world's population is at risk of malaria.

Global antimalarial drugs market can be segmented based on drug type, drug class, route of administration, malaria type, application, distribution channel, company, and region. Based on drug class, the market is segmented into aryl aminoalcohol compounds, antifolate compounds, artemisinin compounds and antimicrobials. Among them, the aryl aminoalcohol compounds segment is expected to witness high growth during the forecast period owing to rising cases of malaria across the world.

Based on route of administration, the global antimalarial drugs market is segmented into oral, powder inhalation and intravenous administration. Among them, the oral segment is expected to undergo high growth through 2028 owing to the advantages such as safety, easy ingestion, pain avoidance and better patient compliance.

Major companies operating in global antimalarial drugs market include Cipla Ltd, GlaxoSmithKline Plc, Ipca Laboratories Ltd., Merck & Co., Inc, Novartis AG, Zydus Cadila, Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), Strides Pharma Science Limited, Glenmark Pharmaceuticals Ltd., and Lincoln Pharmaceuticals Ltd. The market players are adopting growth strategies like new product launches, mergers & partnerships to increase their global market share.

Objective of the Study

  • To analyze and forecast the market size of global antimalarial drugs market.
  • To forecast global antimalarial drugs market based on drug type, drug class, route of administration, malaria type, application, distribution channel, company and regional distribution.
  • To identify drivers and challenges for global antimalarial drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global antimalarial drugs market.
  • To identify and analyse the profile of leading players operating in the global antimalarial drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of antimalarial drugs companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global antimalarial drugs market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Antimalarial drugs companies/partners, investors, and other stakeholders
  • Hospital pharmacy/ retail pharmacy
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to antimalarial drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as antimalarial drugs vendors, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global antimalarial drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Antimalarial Drugs Market, By Drug Type:

  • Quinine
  • Chloroquine
  • Proguanil
  • Amodiaquine
  • Mefloquine
  • Hydroxychloroquine
  • Pyrimethamine
  • Others

Global Antimalarial Drugs Market, By Drug Class:

  • Aryl Aminoalcohol Compounds
  • Antifolate Compounds
  • Artemisinin Compounds
  • Antimicrobials

Global Antimalarial Drugs Market, By Route of Administration:

  • Oral
  • Powder Inhalation
  • Intravenous Administration

Global Antimalarial Drugs Market, By Malaria Type:

  • Plasmodium Falciparum
  • Plasmodium Malariae
  • Plasmodium Vivax
  • Plasmodium Ovale
  • Plasmodium Knowlesi

Global Antimalarial Drugs Market, By Application:

  • Prevention
  • Treatment of Malaria

Global Antimalarial Drugs Market, By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce
  • Others

Global Antimalarial Drugs Market, By Region:

  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Singapore
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • North America
    • United States
    • Mexico
    • Canada
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global antimalarial drugs market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Country
  • 5.8. Clinical Trials Heat Map

6. Global Antimalarial Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Type (Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine, Pyrimethamine, Others)
    • 6.2.2. By Drug Class (Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds, Antimicrobials)
    • 6.2.3. By Route of Administration (Oral, Powder Inhalation, Intravenous Administration)
    • 6.2.4. By Malaria Type (Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Knowlesi)
    • 6.2.5. By Application (Prevention, Treatment of Malaria)
    • 6.2.6. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others)
    • 6.2.7. By Company (2022)
    • 6.2.8. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Antimalarial Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type
    • 7.2.2. By Drug Class
    • 7.2.3. By Route of Administration
    • 7.2.4. By Malaria Type
    • 7.2.5. By Application
    • 7.2.6. By Distribution Channel
    • 7.2.7. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Antimalarial Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Type
        • 7.3.1.2.2. By Drug Class
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By Malaria Type
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By Distribution Channel
    • 7.3.2. India Antimalarial Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Type
        • 7.3.2.2.2. By Drug Class
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By Malaria Type
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By Distribution Channel
    • 7.3.3. Japan Antimalarial Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Type
        • 7.3.3.2.2. By Drug Class
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By Malaria Type
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By Distribution Channel
    • 7.3.4. South Korea Antimalarial Drugs Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Drug Type
        • 7.3.4.2.2. By Drug Class
        • 7.3.4.2.3. By Route of Administration
        • 7.3.4.2.4. By Malaria Type
        • 7.3.4.2.5. By Application
        • 7.3.4.2.6. By Distribution Channel
    • 7.3.5. Singapore Antimalarial Drugs Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Drug Type
        • 7.3.5.2.2. By Drug Class
        • 7.3.5.2.3. By Route of Administration
        • 7.3.5.2.4. By Malaria Type
        • 7.3.5.2.5. By Application
        • 7.3.5.2.6. By Distribution Channel
    • 7.3.6. Australia Antimalarial Drugs Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value & Volume
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Drug Type
        • 7.3.6.2.2. By Drug Class
        • 7.3.6.2.3. By Route of Administration
        • 7.3.6.2.4. By Malaria Type
        • 7.3.6.2.5. By Application
        • 7.3.6.2.6. By Distribution Channel

8. Europe Antimalarial Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type
    • 8.2.2. By Drug Class
    • 8.2.3. By Route of Administration
    • 8.2.4. By Malaria Type
    • 8.2.5. By Application
    • 8.2.6. By Distribution Channel
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Antimalarial Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Drug Class
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By Malaria Type
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By Distribution Channel
    • 8.3.2. Germany Antimalarial Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Drug Class
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By Malaria Type
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By Distribution Channel
    • 8.3.3. United Kingdom Antimalarial Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Drug Class
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By Malaria Type
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By Distribution Channel
    • 8.3.4. Italy Antimalarial Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Type
        • 8.3.4.2.2. By Drug Class
        • 8.3.4.2.3. By Route of Administration
        • 8.3.4.2.4. By Malaria Type
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By Distribution Channel
    • 8.3.5. Spain Antimalarial Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Type
        • 8.3.5.2.2. By Drug Class
        • 8.3.5.2.3. By Route of Administration
        • 8.3.5.2.4. By Malaria Type
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By Distribution Channel

9. North America Antimalarial Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type
    • 9.2.2. By Drug Class
    • 9.2.3. By Route of Administration
    • 9.2.4. By Malaria Type
    • 9.2.5. By Application
    • 9.2.6. By Distribution Channel
    • 9.2.7. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Antimalarial Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Drug Class
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By Malaria Type
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By Distribution Channel
    • 9.3.2. Mexico Antimalarial Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Drug Class
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By Malaria Type
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By Distribution Channel
    • 9.3.3. Canada Antimalarial Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Drug Class
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By Malaria Type
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By Distribution Channel

10. South America Antimalarial Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Type
    • 10.2.2. By Drug Class
    • 10.2.3. By Route of Administration
    • 10.2.4. By Malaria Type
    • 10.2.5. By Application
    • 10.2.6. By Distribution Channel
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Antimalarial Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Type
        • 10.3.1.2.2. By Drug Class
        • 10.3.1.2.3. By Route of Administration
        • 10.3.1.2.4. By Malaria Type
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By Distribution Channel
    • 10.3.2. Argentina Antimalarial Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Drug Class
        • 10.3.2.2.3. By Route of Administration
        • 10.3.2.2.4. By Malaria Type
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By Distribution Channel
    • 10.3.3. Colombia Antimalarial Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Type
        • 10.3.3.2.2. By Drug Class
        • 10.3.3.2.3. By Route of Administration
        • 10.3.3.2.4. By Malaria Type
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By Distribution Channel

11. Middle East and Africa Antimalarial Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Drug Type
    • 11.2.2. By Drug Class
    • 11.2.3. By Route of Administration
    • 11.2.4. By Malaria Type
    • 11.2.5. By Application
    • 11.2.6. By Distribution Channel
    • 11.2.7. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Antimalarial Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value & Volume
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Drug Type
        • 11.3.1.2.2. By Drug Class
        • 11.3.1.2.3. By Route of Administration
        • 11.3.1.2.4. By Malaria Type
        • 11.3.1.2.5. By Application
        • 11.3.1.2.6. By Distribution Channel
    • 11.3.2. Saudi Arabia Antimalarial Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value & Volume
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Drug Type
        • 11.3.2.2.2. By Drug Class
        • 11.3.2.2.3. By Route of Administration
        • 11.3.2.2.4. By Malaria Type
        • 11.3.2.2.5. By Application
        • 11.3.2.2.6. By Distribution Channel
    • 11.3.3. UAE Antimalarial Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value & Volume
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Drug Type
        • 11.3.3.2.2. By Drug Class
        • 11.3.3.2.3. By Route of Administration
        • 11.3.3.2.4. By Malaria Type
        • 11.3.3.2.5. By Application
        • 11.3.3.2.6. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Cipla Ltd
    • 14.2.2. GlaxoSmithKline Plc
    • 14.2.3. Ipca Laboratories Ltd.
    • 14.2.4. Merck & Co., Inc
    • 14.2.5. Novartis AG
    • 14.2.6. Zydus Cadila
    • 14.2.7. Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)
    • 14.2.8. Strides Pharma Science Limited
    • 14.2.9. Glenmark Pharmaceuticals Ltd.
    • 14.2.10. Lincoln Pharmaceuticals Ltd.

15. Strategic Recommendations